Please note: Cancer Center Grand Rounds is on hiatus.

Mass General Cancer Center Grand Rounds is a CME accredited weekly seminar series. Cutting edge topics, case studies and conference highlights will be presented.

Fall 2019 - Spring 2020 Schedule

Location: Simches Research Center, Room 3110
Time: 12:00–1:00 PM
Intended Audience: Internal MGH Faculty and Staff

The Massachusetts General Hospital Cancer Center Grand Rounds program has emerged as a premiere oncology conference in Boston. This program provides an opportunity for Mass General professional staff and fellows to learn from national and international leaders and innovators in cancer treatment and research.

Grand Rounds offers CME credit, and is structured as a 45-minute lecture followed by 15 minutes of discussion and interaction. Please see below to view the weekly topics and presenters.

PLEASE NOTE: Cancer Center Grand Rounds is open ONLY to internal faculty and staff.


October 2019

October 3, 2019
ASCO Update
Ibiayi Dagogo-Jack, MD
Massachusetts General Hospital Cancer Center

Samuel Klempner, MD
Massachusetts General Hospital Cancer Center

Richard Lee, MD, PhD
Massachusetts General Hospital Cancer Center

Neelima Vidula, MD
Massachusetts General Hospital Cancer Center

October 10, 2019
Next Generation CAR for Treatment of Hematologic Malignancies
Jae Park, MD
Associate Attending Physician
Director, Acute Lymphoblastic Leukemia Program
Assistant Director, Cellular Therapeutics Service
Memorial Sloan-Kettering Cancer Center

October 24, 2019
Constructing Next Generation Immune Therapies from Pancreatic Cancer Survivors
Vinod P. Balachandran, MD, FACS
Assistant Attending Surgeon,Hepatopancreatobiliary Service, Department of Surgery
Member Researcher, Parker Institute for Cancer Immunotherapy
Member Researcher, David M. Rubenstein Center for Pancreatic Cancer Research

October 31, 2019
Serous Ovarian Cancer: Advances and Setbacks
David Spriggs, MD
Director of Gynecologic Oncology Program
Massachusetts General Hospital

November 2019

November 14, 2019
Impact of Conditioning Intensity of Allogenic Transplantation for Acute Myeloid Leukemia with Genomic Evidence of Residual Disease
Christopher Hourigan, MD, DPhil
Chief, Laboratory of Myeloid Malignancies in the Hematology Branch
National Heart, Lung and Blood Institute
National Institutes of Health

November 21, 2019
Lippard Lecture: Targeting the Unexpected Origins of Ovarian Cancer
Ronny Drapkin, MD, PhD
Franklin Payne Associate Professor of Pathology in Obstetrics & Gynecology
Director of Gynecological Cancer Research, The Basser Center for BRCA
University of Pennsylvania, Abramson Cancer Center

December 2019

December 5, 2019
Clinical Pathology Conference: A 34-Year-Old Woman with Cholangiocarcinoma
Lipika Goyal, MD
Massachusetts General Hospital Cancer Center

Christopher Chen, MD
Massachusetts General Hospital Cancer Center

Theodore Pierce, MD
Massachusetts General Hospital Cancer Center

Vikram Deshpande, MD
Massachusetts General Hospital

December 12, 2019
New Biology of Pheochromocytoma and Paraganglioma: Implications for its Genetics, Diagnosis, and Treatment
Karel Pacak, MD, PhD, DSc, FACE
Senior Investigator
Chief, Section on Medical Neuroendocrinology
Head, Developmental Endocrinology, Metabolism, Genetics and Endocrine Oncology Affinity Group
Professor of Medicine, Eunice Kennedy Shriver NICHD, NIH

January 2020

January 2, 2020
ASH Update Part 1
Jeremy Abramson, MD
Director, Jon and JoAnn Hagler Center for Lymphoma
Massachusetts General Hospital Cancer Center
Associate Professor of Medicine, Harvard Medical School

Andrew Brunner, MD
Massachusetts General Hospital Cancer Center

January 9, 2020
ASH Update Part 2
Annemarie Fogerty, MD
Massachusetts General Hospital Cancer Center

Yi-Bin Chen, MD
Director, BMT Program
Massachusetts General Hospital Cancer Center

Matthew Frigault, MD
Associate Professor of Medicine, Harvard Medical School

Betsy O'Donnell, MD
Associate Professor of Medicine, Harvard Medical School

January 16, 2020
Role of Lipids in Castration-Resistant Prostate Cancer
Massimo Loda, MD
Professor, Pathology, Harvard Medical School
Principal Investigator, Pathology, Dana-Farber Cancer Institute
Senior Pathologist, Pathology, Brigham And Women's Hospital

January 23, 2020
Changing the Paradigm in PTCL Core
Owen A. O'Connor, MD, PhD
American Cancer Society Research Professor
Professor of Medicine and Experimental Therapeutics
Director, Center for Lymphoid Malignancies
Columbia University Medical Center

January 30, 2020
Developmental Therapeutics for Thyroid Cancer
Alan Ho, MD, PhD
Geoffrey Beene Junior Faculty Chair
Memorial Sloan Kettering Cancer Center

February 2020

February 6, 2020
The Treatment of Young Adults with ALL: Growing UP!
Wendy Stock, MD
Anjuli Seth Nayak Professor in Leukemia
The University of Chicago Medicine

February 13, 2020
1 Tumor, 1 Mutation, and 5 Targeted Agents – Yet Not So Simple
Ron DeMateo, MD, FACS
Chair, Department of Surgery
John Rhea Barton Professor of Surgery
Penn Medicine

February 20, 2020
No Session: School Vacation Week

February 27, 2020
No Session

March 2020

March 5, 2020
Strategies to Address Acquired and Adaptive Resistance in Colorectal Cancer
Scott Kopetz, MD, PhD, FACP
Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine
The University of Texas MD Anderson Cancer Center

March 12, 2020
Session Cancelled

March 19, 2020
How many myelomas are there?
Nikhil Munshi, MD
Director of Basic and Correlative Science, Jerome Lipper Multiple Myeloma Center
Senior Physician, Dana-Farber Cancer Institute
Professor of Medicine, Harvard Medical School

March 26, 2020
No Session

April 2020

April 2, 2020
No Session

April 9, 2020
Late Recurrence and Extended Endocrine Therapy for ER Positive Breast Cancer: the Next Frontier?
Daniel F. Hayes, MD, FACP, FASCO
Stuart B. Padnos Professor of Breast Cancer Research
University of Michigan Rogel Cancer Center

April 16, 2020
Role of Immunotherapy in the Treatment of Lung Cancer
Matthew Hellman, MD
Medical Oncologist
Parker Institute for Cancer Immunotherapy
Memorial Sloan Kettering Cancer Center

April 23, 2020
No Session: School Vacation Week

April 30, 2020
Advances in Premenopausal Breast Cancer
Nancy Davidson, MD
Senior Vice President, Director and Full Member
Clinical Research Division, Fred Hutch
Raisbeck Endowed Chair for Collaborative Research
Fred Hutch
President and Executive Director
Seattle Cancer Care Alliance

May 2020

May 7, 2020
Genomic Screens for Targeted Therapy
Jeffrey Tyner, PhD
Professor of Medicine, School of Medicine
Cell and Developmental Biology Graduate Program School of Medicine
Cancer Biology Graduate Program School of Medicine
Program in Molecular and Cellular Biosciences School of Medicine
Oregon Health & Science University (OHSU)

May 14, 2020
Therapeutic Vaccines for Prostate Cancer
Ravi Madan, MD
Clinical Director
Genitourinary Malignancies Branch
Center for Cancer Research, NCI, NIH

May 21, 2020
Clinical Pathology Conference: Case TBD
Speakers TBD

May 28, 2020
Management of Glioblastoma with Viral Vectors
Evanthia Galanis, MD
Consultant, Division of Medical Oncology, Department of Oncology
Consultant, Department of Molecular Medicine
Professor of Oncology
Mayo Clinic